|
08:45- 09:30
|
Registration and posters set-up
|
|
09:30- 10:00
|
Welcome
|
|
Session: Prion diseases in animals, chairs: Juan Carlos Espinosa (CISA) + Alicia Otero (UNIZAR)
|
10:00- 10:45
|
Camel prion disease: a new emerging disease in North Africa
|
Dr. Laura Pirisinu, Istituto Superiore di Sanita, Italy
|
10:45- 11:00
|
Oral 1: Assessment of the goat I/M142 polymorphism in the susceptibility to atypical scrapie prions
|
Natalia Fernández-Borges
|
11:00- 11:15
|
Oral 2: Innate immune status of glia and prion replication
|
Sang-Gyun Kang
|
11:15- 11:30
|
Oral 3: sPMCA conversion efficacies of Norwegian prions
|
Cecile Ersdal
|
|
11:30- 12:00
|
Coffee break & Posters
|
|
Session: Prion diseases in animals, chairs: Leonor Orge (UTAD) + Tomás Barrio (ENVT)
|
12:00- 12:15
|
Oral 4: Atypical scrapie evolution during propagation in different PrPC subtract both in vitro and in vivo
|
Sara Canoyra
|
12:15- 12:30
|
Oral 5: In vitro modelling of cervid prion strain emergence and evolution considering all the described polymorphic variants
|
Carlos M. Díaz-Domínguez
|
12:30- 12:45
|
Oral 6: Vaccines for chronic wasting disease
|
Hermann Schatzl
|
12:45- 13:30
|
Interventional clinical trials in human prion diseases: is now the time?
|
Dr. Raquel Sánchez-Valle, Hospital Clínic de Barcelona, Spain
|
|
13:30- 15:00
|
Lunch & Posters & Group photo
|
|
Session: Prion and prion-like diseases in humans, chairs: Jokin Castilla (CIC bioGUNE) + Natalia Sanchez de Groot (UAB)
|
15:00- 15:45
|
Strain-specific lesioning patterns in sporadic CJD - a neuropathological perspective
|
Dr. Ellen Gelpi, Medical University of Vienna, Austria
|
15:45- 15:50
|
Genetic CJD Biobank
|
Alice Ananne
|
15:50- 16:05
|
Oral 7: Human prion strain discrimination by RT-QuIC
|
Alba Marín-Moreno
|
16:05- 16:20
|
Oral 8: Gene therapy for sCJD in a humanized mouse model
|
Qingzhong Kong
|
16:20- 16:35
|
Oral 9: A robust method for evaluation of prionicide treatments
|
Angélique Igel
|
16:35- 17:05
|
Coffee break & Posters
|
|
Session: Prion and prion-like diseases in humans, chairs: Jesús Requena (CiMUS USC) + Michał Burdukiewicz (UAB)
|
17:05- 17:20
|
Oral 10: Neuronal Networks in absence of the prion protein
|
Ana Burato
|
17:20- 17:35
|
Oral 11: The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains
|
Samuel Peña
|
17:35- 17:50
|
Oral 12: The structural architecture of an α-synuclein toxic oligomer
|
Jaime Santos
|
17:50- 18:35
|
Thirty years of cohabitation with prion diseases: my personal experience
|
Dr. Martí Pumarola, Universitat Autònoma de Barcelona, Spain
|
|
21:00- 00:00
|
Congress dinner at bullfighting arena
|
|